<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11535">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01824706</url>
  </required_header>
  <id_info>
    <org_study_id>NT-PMK-1201</org_study_id>
    <nct_id>NCT01824706</nct_id>
  </id_info>
  <brief_title>Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant</brief_title>
  <acronym>CUSTOMBONE</acronym>
  <official_title>A Prospective, Multicenter Observational Study Evaluating the Long Term Safety in Terms of Explantation Rate and Number of Infections of the Custom-made Bioceramic Implant CustomBone™</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Codman &amp; Shurtleff</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Codman &amp; Shurtleff</source>
  <oversight_info>
    <authority>France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Prospective, Multicenter Observational Study Evaluating the Long Term Safety in Terms of
      Explantation Rate and Number of Infections of the Custom-made Bioceramic Implant CustomBone™

      The patients will be included as soon as they are ilplanted and follow-up for 2 years. It is
      observationnal so no specific exam is planned.

      The explantation rate will be measured, that is to say the number of patients whose
      prosthesis will be removed (with or without any relationship with the implant or the
      procedure).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Explantation rate after 2 years of follow-up</measure>
    <time_frame>24 months after implantation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The main objective of the study is to measure the explantation rate after the implantation of a custombone TM prosthesis. We will measure the number of patients whose prosthesis has an been removed, with or without any relationship with the implant or the procedure</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>craniectomy</arm_group_label>
    <description>craniectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>craniectomy</intervention_name>
    <description>craniectomy</description>
    <arm_group_label>craniectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patient implanted with the Custombone prosthesis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient planning to have a  cranioplasty and be implanted with the Custombone™
             medical device

          -  Patient who agrees to take part in the study, or agreement of a representative of the
             patient in case of patient inability, after being informed by the investigator and
             having received an information letter

        Exclusion criteria:

        - Patient who does not accept to take part in the study after being informed
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>S Froelich</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Lariboisiere Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaud Nicolas</last_name>
    <role>Study Chair</role>
    <affiliation>Codman</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>J Peltier</last_name>
      <phone>+33322668340</phone>
      <email>peltier.johann@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>J Peltier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P Menei</last_name>
      <phone>+33241354822</phone>
      <email>phmenei@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>P Menei</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la cote basque</name>
      <address>
        <city>Bayonne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>P Caillaud</last_name>
      <phone>+33559443544</phone>
      <email>pcaillaud002@ch-cotebasque.fr</email>
    </contact>
    <investigator>
      <last_name>P Caillaud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU la cavale blanche</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P Dam Hieu</last_name>
      <phone>+33298347317</phone>
      <email>phongdamhieu@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>P Dam Hieu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Beaujon</name>
      <address>
        <city>Clichy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>T Faillot</last_name>
      <phone>+33140875254</phone>
      <email>thierry.faillot@bjn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>T Faillot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>C Le Guerinel</last_name>
      <phone>+33149812209</phone>
      <email>caroline.le-guerinel@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>C Le Guerinel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Roger Salengro</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Baroncini</last_name>
      <phone>+33320446635</phone>
      <email>marc.baroncini@inserm.fr</email>
    </contact>
    <investigator>
      <last_name>Marc Baroncini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JP Lejeune</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>C Mottolese</last_name>
      <phone>+33472357572</phone>
      <email>carmine.mottolese@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>C Mottolese</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>D Scavarda</last_name>
      <phone>+33491385545</phone>
      <email>didier.scavarda@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>D Scavarda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hotel Dieu</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>K Buffenoir</last_name>
      <phone>+33240083787</phone>
      <email>kevin.buffenoirbillet@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>K Buffenoir</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Pasteur</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Lonjon</last_name>
      <phone>+33492037958</phone>
      <email>lonjon.m@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>M Lonjon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lariboisière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S Froelich</last_name>
      <phone>+33149958144</phone>
      <email>sebastien.froelich@lrb.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>S Froelich</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU La¨Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>P Cornu</last_name>
      <phone>+33142163411</phone>
      <email>philippe.cornu@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>P Caillaud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Maison Blanche</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>P Peruzzi</last_name>
      <phone>+33326789431</phone>
      <email>pperuzzi@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>P Peruzzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Ponchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PL Henaux</last_name>
      <phone>+33299284277</phone>
      <email>pierre-louis@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>PL Henaux</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Saint Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>C Nuti</last_name>
      <phone>+33477127723</phone>
      <email>christophe.nuti@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>C Nuti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Lahlou</last_name>
      <phone>+33388127619</phone>
      <email>mohamedamine.lahlou@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>M Lahlou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Bretonneau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P François</last_name>
      <phone>+33218370813</phone>
      <email>francois@med.univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>P François</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Tonkin</name>
      <address>
        <city>Villeurbanne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>K Mahla</last_name>
      <phone>+33478945760</phone>
      <email>kmahla@capio.fr</email>
    </contact>
    <investigator>
      <last_name>K Mahla</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>March 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cranial prosthesis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
